ETFs & Funds
View as an RSS Feed
Gene Therapy: Which Companies To Invest In?
i'd also suggest a look at Gradalis for gene therapy Vs cancer (7 phase I / II trials underway), and Benitec, who have the dominant RNAi gene therapy patent portfolio, of which Gradalis will likley need to licence.
The father of gene therapy, James Watson, recently put out a strong statement supporting RNAi in the battle against cancer.
Jan 29, 2013. 01:20 AM
Link to Comment